Key facts
- This page summarizes Joseph H. Dawson's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Nov 2025, 19:37.
Joseph H. Dawson - 17 Nov 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)
- Reporting relationship
- Director
- Issuer ticker
- RMTI
- Reported as of
- 17 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2025, 19:37:17 UTC
- Next SEC filing
- 06 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Megan Timmins, Attorney-in-Fact for Joseph Dawson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph H. Dawson filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 20 Nov 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002097560
Primary reporting owner
Dawson Joseph H
- Relationship
- Director
- Address
- C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM
- Signature
- /s/ Megan Timmins, Attorney-in-Fact for Joseph Dawson
- Signature date
- 20 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMTI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RMTI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $0.8700
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
Stock options vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.
SEC remarks
This Form 4 is being filed late due to administrative delays in obtaining the Reporting Person's EDGAR codes.